Rare pediatric diseases frequently present with complex and severe clinical phenotypes that confound traditional diagnostic approaches. Families often face a prolonged and costly diagnostic odyssey, marked by numerous specialist consultations, inconclusive genetic findings, and a vastly growing uncertainty about their child’s condition. The TUDP was conceived as a structured, centralized national program designed to surmount these challenges by harnessing advanced genomic technologies integrated within a robust clinical network. Spanning 1,300 children evaluated across 22 specialist centers between 2016 and 2023, the program’s longitudinal data highlight the efficacy of coordinated genomic medicine at a systemic scale.

Central to the program’s success is its rigorous patient selection criteria, focusing exclusively on pediatric cases under 18 with severe phenotypes that remained unsolved despite prior genomic testing. This selective enrollment approach ensures the cohort’s clinical complexity while fostering enhanced interpretative clarity when confronted with genetic data. Samples from enrolled children are processed through trio-based exome sequencing at TIGEM’s centralized genomics laboratory. This trio sequencing strategy—simultaneous sequencing of the affected child and both parents—maximizes detection sensitivity for de novo pathogenic variants, which constitute over 70% of the causative genetic alterations identified.

The TUDP boasts a diagnostic yield of 49%, ranking among the highest in global undiagnosed disease programs. This impressive figure underscores the utility of a cohesive national framework, integrating cutting-edge sequencing technologies with multidisciplinary expertise. Genomic analyses have pinpointed pathogenic variants spanning more than 330 genes, reflecting the profound genetic heterogeneity intrinsic to pediatric rare diseases. The detection of largely de novo mutations attests to the importance of trio sequencing in unraveling mutations arising spontaneously, which lack prior familial precedent yet drive disease phenotypes.

Speed and efficiency in generating actionable genetic insights have been transformative for participating families. The program routinely delivers molecular diagnosis within 12 to 18 months from enrollment, markedly shortening the diagnostic timeline, especially for children born after the program’s institution in 2016. Streamlining early access to comprehensive genomic evaluations circumvents the traditional years-long pursuit of diagnostic certainty that has historically eluded many families.

Beyond providing elusive molecular labels, the significance of diagnosis extends into transformative clinical and psychosocial dimensions. For children burdened with severe disorders, a precise genetic diagnosis enables tailored clinical management and guides prognostication. Importantly, it facilitates evidence-based genetic counseling, allowing families to make informed reproductive decisions and anticipate future health outcomes. Moreover, diagnoses increasingly pave the way toward access to precision therapies, including antisense oligonucleotides, gene therapy modalities, and pharmacogenomic interventions customized according to variant-specific pathogenicity.

A distinctive and innovative feature of the TUDP model lies in its commitment to perpetual genomic data reanalysis. Recognizing that unsolved cases are not terminal dead-ends but reservoirs of latent genetic insight, the program conducts systematic reexamination of sequencing datasets in light of expanding scientific knowledge and evolving bioinformatic tools. This ongoing reanalysis has already augmented diagnostic yield by over 17% in previously negative cases, exemplifying how iterative data interrogation can unlock new diagnostic potentials and accelerate discovery in real-time genomic medicine.

The program also serves as a powerful engine for scientific discovery, bridging clinical diagnostics with novel gene identification. During its initial eight years, the TUDP has been instrumental in validating 16 novel disease-causing genes, substantiated through rigorous functional assays in model organisms and corroborated by international collaborative networks. An additional 14 candidate genes remain under active investigation, emphasizing the dynamic and evolving landscape of rare disease genomics, where much of the genetic etiology remains to be elucidated.

Collaborative platforms like Matchmaker Exchange have been pivotal in accelerating gene-disease association by enabling the global matching of phenotypically and genotypically similar patients. This cross-border data integration leverages patient clustering to strengthen causality assertions for newly discovered genes, expediting translational insights that benefit patients worldwide. Within this context, a recent landmark achievement involved identifying 11 probands with pathogenic de novo variants in RNU4-2, a non-coding RNA gene newly implicated in the ReNU syndrome neurodevelopmental disorder, a breakthrough enabled exclusively through the program’s sustained reanalysis framework.

Embedded within a vibrant international consortium, the TUDP exemplifies excellence in rare disease genomics cooperation. It is a full member of the Undiagnosed Diseases Network International (UDNI), contributing expertise and datasets to the European Commission’s Solve-RD project, which further enhances analytical power through integration with European Reference Networks. Data sharing across diverse genomic repositories, including PhenomeCentral, Decipher, and ClinVar, facilitates unmatched cross-institutional synergy, accelerating gene discoveries and optimizing diagnostic returns.

Post-diagnostic support is an integral facet of the program, with families receiving comprehensive guidance via Fondazione Telethon’s InfoRare service. This resource acts as a nexus between patients, research advancements, referral centers, patient advocacy groups, and clinical trial opportunities, ensuring that diagnoses translate into tangible benefits beyond the laboratory, forging a continuum of care and empowerment.

Looking forward, the TUDP is evolving its technological arsenal, transitioning towards trio whole genome sequencing (WGS) as the entry point test, augmented by artificial intelligence algorithms for variant classification. The adoption of WGS expands the capacity to detect structural variants, non-coding regulatory mutations, and complex rearrangements inadequately captured by exome sequencing. Complementary methodologies such as long-read sequencing, optical genome mapping, and RNA sequencing are incorporated for unresolved or structurally intricate cases, sharpening diagnostic acuity.

Crucially, the program embraces unsolved cases as valuable scientific challenges and assets, not failures. As genomics and molecular biology progress, today’s unresolved datasets harbor the potential to transform into tomorrow’s definitive diagnoses and therapeutic targets. The TUDP thus embodies a model of iterative discovery, collaborative integration, and patient-centered genomic medicine that promises to redefine the future landscape of rare childhood disease diagnostics globally.

Subject of Research: Animal tissue samples
Article Title: Telethon Undiagnosed Disease Program: Structured approach to solving rare childhood-onset genetic diseases
News Publication Date: 18-Apr-2026
Web References:

• Genetics in Medicine Open publication
• Matchmaker Exchange
• Undiagnosed Diseases Network International (UDNI)
• Solve-RD project

References:
DOI: 10.1016/j.gimo.2026.104394

Image Credits: Fondazione Telethon

Keywords: rare diseases, pediatric genomics, genetic diagnosis, trio exome sequencing, de novo mutations, gene discovery, reanalysis, whole genome sequencing, precision medicine, Telethon Undiagnosed Disease Program, TIGEM, undiagnosed diseases

The study’s approach capitalized on high-resolution longitudinal genomic data, allowing for the detection of adaptive shifts in gene frequencies within microbial populations over time. Unlike traditional population genetics methods that survey genome-wide patterns, the iLDS method pinpoints sweeping alleles that confer selective advantages, highlighting the precise genetic targets of natural selection. Researchers discovered a median of four selective sweeps per species, reflecting a remarkable degree of ongoing adaptive evolution shaping microbiome functionality.

Among the 447 genes implicated within these selective sweeps, the functional diversity was immense, yet certain gene categories repeatedly emerged as hotspots of selection. Notably, genes associated with carbohydrate transport and metabolism showed robust enrichment signals, emphasizing their evolutionary importance in the gut ecosphere. The statistical analysis, including rigorous correction for multiple hypothesis testing, implicated carbohydrate metabolism-related genes at an extraordinary significance threshold (adjusted single-sided p-value less than 5×10⁻⁷).

The prominence of carbohydrate metabolizing genes under strong selection aligns neatly with the ecological context of the human gut, where dietary carbohydrates serve as a primary energy source for resident microbes. Within this category of genes, glycoside hydrolases — enzymes essential for breaking down complex carbohydrates — were particularly overrepresented. These enzymes facilitate the catabolism of dietary polysaccharides, enabling microbial competitors to exploit an abundant resource, thereby gaining a selective edge.

A particularly intriguing finding involved the identification of selective sweeps in the susC/susD gene clusters across five distinct bacterial species. The susC/susD system mediates starch utilization and has previously been implicated in adaptive processes within individual human hosts over relatively short timescales. Its recurrence across multiple gut species bolsters the idea that starch metabolism genes constitute a key adaptive target in the microbial arms race for nutritional niches.

Beyond starch utilization, the study spotlighted the ABC transporters mdxE and mdxF, capable of metabolizing maltodextrin — a starch derivative widely used in modern ultra-processed foods. Although these genes were present in only four species within the dataset, iLDS identified selection signatures in two of them, Eubacterium siraeum and Ruminococcus bromii. Both species are recognized starch degraders, and the adaptive signals involving mdxEF genes suggest recent, perhaps diet-driven, selection pressures shaping their functional repertoires.

Further genetic scrutiny revealed evidence of extensive recent horizontal gene transfer (HGT) at and around the mdxEF locus, consistent with a selective sweep phenomenon. Such a pattern indicates that advantageous genetic material is not only evolving in situ but is also being exchanged between microbial lineages, enhancing their capacity to metabolize complex carbohydrates in response to dietary inputs. The interplay of HGT and selective sweeps underscores the complex evolutionary mechanisms sculpting gut microbial genomes.

The implications of these discoveries are far-reaching. Microbial adaptation through gene-specific selective sweeps may underpin how gut microbiomes maintain functional resilience and respond to environmental perturbations, including dietary shifts. Understanding these evolutionary dynamics can inform efforts to manipulate microbiomes for improved human health, guiding personalized nutrition, probiotics, or microbiota-targeted therapies.

It is notable that the study’s comprehensive dataset allowed for cross-species comparisons, revealing convergent evolutionary trends in carbohydrate metabolism genes. These cross-cutting adaptive themes suggest a shared selective landscape sculpted by host diet and physiology. The convergence observed emphasizes the pivotal role of carbohydrate processing machinery as an evolutionary battleground within the gut ecosystem.

Additionally, the research highlights maltodextrin metabolism as a potentially critical adaptive function in bacterial strains colonizing hosts consuming processed Western diets rich in starch derivatives. This finding links human dietary practices directly with microbial evolutionary trajectories, adding an important dimension to our understanding of diet-microbiome interactions and their evolutionary consequences.

Technologically, the iLDS framework represents a sophisticated advance in microbial genomics, integrating longitudinal sampling with precise statistical modeling to illuminate gene-level evolutionary events previously obscured by population complexity and horizontal gene flux. By moving beyond broader genomic signals to pinpoint specific gene targets under selection, the methodology opens promising avenues for elucidating microbial evolutionary ecology with greater precision.

As our appreciation grows for the dynamic and adaptive nature of gut microbiomes, studies such as this underscore the importance of investigating evolutionary processes at the gene level. Selective sweeps focused on carbohydrate metabolism genes exemplify how microbial communities tailor their functional capacities in real time to align with host environments, dietary landscapes, and interspecies competition. These insights pave the way for future research exploring the mechanisms and consequences of microbial adaptation within human hosts.

Collectively, this work provides compelling evidence that gene-specific selective sweeps are not isolated or rare events but are instead widespread across diverse species inhabiting the human gut. This pervasive adaptive pattern challenges static views of microbial populations and underscores the gut microbiome as a dynamic evolutionary arena where genetic innovations propagate swiftly.

Ultimately, the newfound understanding of selective pressure targeting carbohydrate metabolism genes enhances our fundamental grasp of microbiome-host coevolution and offers a foundation for translating evolutionary insights into health applications. As the field progresses, integrating evolutionary genomics with microbiome science promises transformative impacts on medicine, nutrition, and biotechnology.

Subject of Research: Evolutionary dynamics and selective sweeps in human gut microbiome species, focusing on gene-specific adaptations related to carbohydrate metabolism.

Article Title: Gene-specific selective sweeps are pervasive across human gut microbiomes.

Article References:
Wolff, R., Garud, N.R. Gene-specific selective sweeps are pervasive across human gut microbiomes. Nature (2025). https://doi.org/10.1038/s41586-025-09798-y

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41586-025-09798-y

Keywords: Gut microbiome, selective sweeps, gene-specific adaptation, carbohydrate metabolism, microbial evolution, horizontal gene transfer, starch utilization, maltodextrin metabolism, iLDS methodology, glycoside hydrolases, microbial genomics, host-microbiome interactions